The Role of Regulatory Non-Coding RNA in Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 66
Special Issue Editors
Interests: tumor biology; melanoma; skin cancers; photobiology; photochemistry
Special Issues, Collections and Topics in MDPI journals
Interests: melanoma; melanin biochemistry; skin pigmentation; melanin chemiexcitation; human genetics; and environmental carcinogenicity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Although initially presumed to be non-functional, numerous studies in the past decade have established the indispensable functions of non-coding RNAs (ncRNAs), including in chromatin remodeling and transcriptional and post-transcriptional regulation. In cancer, some types of ncRNA have been implicated in events of initiation and progression. These include microRNAs (miRNAs), long non-coding RNAs (lncRNAs), small interfering RNAs (siRNAs), PIWI-interacting RNAs, small nucleolar RNAs (snoRNAs), and sno-derived RNAs. Most studies discuss the involvement of miRNAs, siRNAs, and lncRNAs in different cancers, but other ncRNA types are also supposed to make significant contributions to carcinogenesis.
Since ncRNAs are critical in cancer development and metastasis, this Special Issue will not only describe the novel ncRNAs but also the unexplored mechanisms by which these ncRNAs regulate distinct aspects of carcinogenesis. This Special Issue will also focus on the therapeutic targeting of these ncRNAs in order to develop and optimize anticancer strategies. Moreover, this Special Issue will discuss whether the specific ncRNAs have tissue and/or cancer type-specific roles and regulation.
Dr. Jyoti Srivastava
Dr. Sanjay Premi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer initiation
- cancer progression
- metastasis
- ncRNAs
- miRNAs
- lncRNAs
- gene regulation
- chromatin remodeling
- targeted therapeutics
